Tag: BASIL-2
Endovascular showdown: CX 2024 sets the stage for BASIL-3 first-time data...
At the Charing Cross (CX) Symposium 2024 (23–25 April, London, UK), Andrew Bradbury (University of Birmingham, Birmingham, UK) and the BASIL-3 team of triallists...
BEST-CLI: One year on
A dedicated session at the 2023 VEITHsymposium (14–18 November, New York, USA) aimed to unpack the ways in which clinical practice and attitudes in...
Obituary: Roger M Greenhalgh 6th February 1941 – 6th October 2023
Roger Malcolm Greenhalgh, the surgeon internationally renowned for his unparalleled contribution to vascular education, training and research, died peacefully on 6th October, aged 82....
Vascular News’ top 10 most popular stories of April 2023
April's top 10 sees a product announcement from Terumo Aortic take the top spot, with highlights from the 2023 Charing Cross (CX) International Symposium...
BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients
A question from Manj Gohel (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) on what the Charing Cross (CX) audience should take back to...
BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients
A question from Manj Gohel (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) on what the Charing Cross (CX) audience should take back to...
CX 2023 highlight: The BASIL-2 trial
Data and discussion on revascularisation treatment strategies for patients with chronic limb-threatening ischaemia (CLTI) will take centre stage at the CX 2023 Consensus update,...
Vascular News 97 – February 2023 US Edition
In this issue:
CX 2023 preview: Headline peripheral session to spotlight audience view on new BASIL-2 findings
Journal highlight: Individual patient data meta-analysis probes safety...
